Prepared by Dr. Sofia Chen, CFA, Director of US Markets | Reviewed by David Miller, Lead Editor | Report ID: IGEMINI-16AC5811-20260531 | Data as of 2026-05-31
Executive Summary: Our multi-factor model assigns neuro one stock a Bullish outlook for the next quarter. Key drivers include a P/E of 31.33x, 43.6% revenue expansion, and an RSI of 56 suggesting a neutral-bullish phase. We define critical support at $1683.9 and resistance at $2058.1.
Rating: Buy | Target Price: $2507.14 | Next Earnings: Jul 04
Download Full PDF Report
Bollinger Bands contracted to the 15th percentile, signaling a breakout. A close above $2151.65 would be bullish.
On-chain money flow shows 32%% increase in smart money index, reinforcing the technical setup.
Price action carved a Ascending Triangle, confirmed by a 1.74x volume spike on May 02, 2026. The resistance at $2058.1 was tested.
Relative to Real Estate peers, neuro one stock sits at the 65th percentile in valuation, offering a potential value opportunity.
Free cash flow conversion remains robust at 95%, supporting the 2.6% dividend and buybacks.
With a market cap of $8.65B, neuro one stock operates in Real Estate. P/E of 31.33x is backed by 43.6% growth.
Beta of 1.51 suggests neuro one stock is {beta_desc} volatile than the market, influencing hedging strategies.
Short float at 3.6% is below the sector average, reducing squeeze risk. Institutional ownership is 89%.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $1871 | $1777.45 |
| Market Cap | $8.65B | $9.52B |
| P/E Ratio | 31.33x | 26.6x |
| EPS (TTM) | $59.72 | $53.75 |
| Dividend Yield | 2.6% | 1.8% |
| Revenue Growth | 43.6% | 26.2% |
| Target Price | $2507.14 | - |
| Beta | 1.51 | 1.00 |